Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Sarja:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Aiheet:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Linkit:https://www.rpcardio.com/jour/article/view/1769
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia